Cited by 351Treatment of Major DepressionMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Efficacy and Tolerability of Tricyclic Antidepressants and SSRIs Compared With Placebo for Treatment of Depression in Primary Care: A Meta-Analysis

Open access

Arroll, B.·2005·The Annals of Family Medicine

DOI 10.1370/afm.349PMC PMC1466912

Open this paper in CoChat — free account Open PDF

Abstract

PURPOSE: Depression is common in primary care. There are no systematic reviews of depression treatment comparing antidepressants with placebo; hence, we do not know whether these medications are effective in primary care. METHODS: We searched the Cochrane Collaboration Depression, Anxiety and Neurosis Group register of controlled trials, MEDLINE, International Pharmaceutical abstracts, PsycINFO, and EMBASE. Abstracts of potential studies were reviewed independently by 2 authors. Studies needed to include randomized controlled trials of either a tricyclic antidepressant (TCA) or selective serotonin reuptake inhibitor (SSRI), or both, and placebo in a primary care setting. The data and quality of the studies were extracted and assessed by 2 authors blind to the other's choice. Disagreements were resolved by discussion. The main outcome measures were the standardized mean difference and weighted mean difference of the final mean depression scores, the relative risk of improvement, and the number withdrawing because of side effects. Pooling of results was done using Review Manager 4.2.2. RESULTS: There were 10 studies in which TCAs were compared with placebo, 3 in which SSRIs were compared with placebo, and 2 with both compared with placebo. One half of the studies were of low methodological quality, and nearly all studies were of short duration, typically 6 to 8 weeks. Pooled estimates of efficacy data showed a relative risk of 1.26 (95% CI, 1.12-1.42) for improvement with TCAs compared with placebo; For SSRIs, relative risk was 1.37 (95% CI, 1.21-1.55). Most patients, 56% to 60%, responded well to active treatment compared with 42% to 47% for placebo. The number needed to treat for TCAs was about 4, and for SSRIs it was 6. The numbers needed to harm (for withdrawal caused by side effects) ranged from 5 to 11 for TCAs and 21 to 94 for SSRIs. Low-dose (100 mg or 75 mg) as well as high-dose TCAs were effective. CONCLUSION: This systematic review is the first comparing antidepressants with placebo for treatment of depression in primary care. Both TCAs and SSRIs are effective. This review is also the first to show that low-dose TCAs are effective in primary care. Prescribing antidepressants in primary care is a more effective clinical activity than prescribing placebo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1370/afm.349

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Is primary care essential?
Starfield, B. H. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90634-3 · Cited by 1,153
Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care
Mynors‐Wallis, L., Gath, D. H., Lloyd-Thomas, A. R., & Tomlinson, D. (1995) · BMJ · doi:10.1136/bmj.310.6977.441 · Cited by 491
The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration.
Kirsch, I., Moore, T. J., Scoboria, A., & Nicholls, S. S. (2002) · Prevention & Treatment · doi:10.1037/1522-3736.5.1.523a · Cited by 430
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
Williams, J. W., Mulrow, C. D., Chiquette, E., Noël, P. H., Aguilar, C., & Cornell, J. E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-9-200005020-00011 · Cited by 419
Cochrane Collaboration Handbook
Mulrow, C. (1996) · Medical Entomology and Zoology · Cited by 403
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
Moher, D., Cook, Jadad, Tugwell, P., Moher, Jones, Pham, & Klassen (1999) · Health Technology Assessment · doi:10.3310/hta3120 · Cited by 364
Meta-analytical studies on new antidepressants
Anderson, I. M. (2001) · British Medical Bulletin · doi:10.1093/bmb/57.1.161 · Cited by 350
Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis
Anderson, I. M., & Tomenson, B. (1995) · BMJ · doi:10.1136/bmj.310.6992.1433 · Cited by 307
Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis
MacGillivray, S., Arroll, B., Hatcher, S., Ogston, S., Reid, I., Sullivan, F., Williams, B., & Crombie, I. (2003) · BMJ · doi:10.1136/bmj.326.7397.1014 · Cited by 265
Self-citation

Show all 40 references

Research works printed but not linked: 9

Suh T, Gallo JJ. The management of depression among general medical service providers. Psychol Med. 1999;27:1051-1063.
Cochrane Collaboration Depression Anxiety and Neurosis Review Group. Available at: http://www.cochrane.org.
Ellis PM, Smith DA. Treating depression: the beyond blue guidelines for treating depression in primary care. Med J Aust. 2002;176:S77-S83.
Philipp M, Kohnen R, Hiller KO. Hypercium extract versus imipramine or placebo in patients with moderate depression: randomised multi- centre study of treatment for eight weeks. BMJ. 1999;319:1534-1539.
Feighner JP, Brauzer B, Gelenberg AJ, et al. A placebo-controlled mulitcenter trial of limbitrol versus its components amitriptyline and chlordiazepoxide. Psychopharmacol. 1979;61:217-225.
Lecrubier Y, Bourin M, Moon CA, et al. Effi cacy of venlafaxine in depressive illness. Acta Psychiatr Scand. 1997;95:485-493.
Brink CW, vdKrogt JP, Dunbar GC, Behagel LH. A controlled clinical trial of mianserin and placebo in the treatment of depression in gen- eral practice. J Drug Ther Res. 1984;9:513-517.
Williams JW, Mulrow CD, Chiquette E, Noel PH, Acaster C, Cornell J. a systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000;132:743-756.
Steffens DC, Krishnan KR, Helms MJ. Are SSRIs better than TCAs? Comparison of SSRIS and TCAs: a meta-analysis. Depress Anxiety. 1997;6:10-18.

Sorted by citations

PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372
Emotion-based dispositions to rash action: positive and negative urgency
Cyders, M. A., & Smith, G. T. (2008) · Psychological Bulletin · doi:10.1037/a0013341 · Cited by 1,136
Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder
Blumenthal, J. A., Babyak, M. A., Doraiswamy, P. M., Watkins, L., Hoffman, B. M., Barbour, K. A., Herman, S., Craighead, W. E., Brosse, A. L., Waugh, R., et al. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318148c19a · Cited by 1,019
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 909
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Sertraline versus other antidepressive agents for depression
Cipriani, A., Ferla, T. L., Furukawa, T. A., Signoretti, A., Nakagawa, A., Churchill, R. C., McGuire, H., & Barbui, C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006117.pub4 · Cited by 512
Biological, Psychological, and Social Determinants of Depression: A Review of Recent Literature
Remes, O., Mendes, J. F., & Templeton, P. (2021) · Brain Sciences · doi:10.3390/brainsci11121633 · Cited by 482
Antidepressants versus placebo for depression in primary care
Arroll, B., Elley, C. R., Fishman, T., Goodyear‐Smith, F., Kenealy, T. W., Blashki, G. A., Kerse, N. M., & MacGillivray, S. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007954 · Cited by 353
Self-citation
Randomized clinical trial of real-time fMRI amygdala neurofeedback for major depressive disorder: effects on symptoms and autobiographical memory recall
Young, K. D., Siegle, G. J., Zotev, V., Phillips, R., Misaki, M., Yuan, H., Drevets, W. C., & Bodurka, J. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16060637 · Cited by 331
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R. C., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 314
Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review
O’Connor, E., Whitlock, E. P., Beil, T. L., & Gaynes, B. N. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-11-200912010-00007 · Cited by 279
Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior
Lukić, I., Getselter, D., Oren, Z., Oron, O., Reuveni, E., Koren, O., & Elliott, E. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0466-x · Cited by 283
The effectiveness and safety of acupuncture therapy in depressive disorders: Systematic review and meta-analysis
Zhang, Z., Chen, H., Yip, K.-C., Ng, R., & Wong, V. T. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.07.005 · Cited by 238
Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis
Singh, S. P., Singh, V., Kar, N., & Chan, K. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067710 · Cited by 220
The evolution of evidence hierarchies: what can Bradford Hill's ‘guidelines for causation’ contribute?
Howick, J., Glasziou, P., & Aronson, J. K. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2009.090020 · Cited by 217
Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder
Jazayeri, S., Tehrani‐Doost, M., Keshavarz, S. A., Hosseini, M., Djazayery, A., Amini‎, H., Jalali, M., & Peet, M. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701827275 · Cited by 224
The drugs don’t work? antidepressants and the current and future pharmacological management of depression
Penn, E., & Tracy, D. K. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312445469 · Cited by 222
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis
Fiest, K. M., Walker, J. R., Bernstein, C. N., Graff, L. A., Zarychanski, R., Abou-Setta, A. M., Patten, S. B., Sareen, J., Bolton, J. M., Marriott, J. J., et al. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.10.004 · Cited by 198
The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis
Riekert, K. A., Bartlett, S. J., Boyle, M. P., Krishnan, J. A., & Rand, C. S. (2007) · Chest · doi:10.1378/chest.06-2474 · Cited by 197
Meta‐analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non‐steroidal anti‐inflammatory drugs
Loke, Y. K., Trivedi, A. N., & Singh, S. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03541.x · Cited by 193
Prescribing patterns of antidepressants in Europe: results from the factors influencing depression endpoints research (FINDER) study
Bauer, M., Monz, B. U., Montejo, A. L., Quail, D., Dantchev, N., Demyttenaere, K., Garcia-Cebrian, A., Grassi, L., Perahia, D. G. S., Reed, C., et al. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2007.11.001 · Cited by 186
Antidepressant treatment for postnatal depression
Molyneaux, E., Howard, L. M., McGeown, H. R., Karia, A. M., & Trevillion, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002018.pub2 · Cited by 171
Inhalation Aromatherapy via Brain-Targeted Nasal Delivery: Natural Volatiles or Essential Oils on Mood Disorders
Cui, J., Li, M., Wei, Y., Li, H., He, X., Yang, Q., Li, Z., Duan, J., Wu, Z. L., Chen, Q., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.860043 · Cited by 188
Duloxetine versus other anti-depressive agents for depression
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533.pub2 · Cited by 172
Mirtazapine versus other antidepressive agents for depression
Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., Churchill, R. C., & Furukawa, T. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006528.pub2 · Cited by 166
Efficacy and Acceptability of Pharmacological Treatments for Depressive Disorders in Primary Care: Systematic Review and Network Meta-Analysis
Linde, K., Kriston, L., Rücker, G., Jamil, S., Schumann, I., Meißner, K., Sigterman, K. E., & Schneider, A. (2015) · The Annals of Family Medicine · doi:10.1370/afm.1687 · Cited by 160
Drug–gut microbiota interactions: implications for neuropharmacology
Walsh, J., Griffin, B. T., Clarke, G. A., & Hyland, N. P. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14366 · Cited by 155
Mental health risk factors for suicides in the US Army, 2007–8
Bachynski, K., Canham-Chervak, M., Black, S. A., Dada, E. O., Millikan, A. M., & Jones, B. H. (2012) · Injury Prevention · doi:10.1136/injuryprev-2011-040112 · Cited by 158
The benefit of combined acupuncture and antidepressant medication for depression: A systematic review and meta-analysis
Chan, Y.-Y., Lo, W.-Y., Yang, S.-N., Chen, Y.-H., & Lin, J.-G. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.01.048 · Cited by 148
Pathophysiology and Current Drug Treatments for Post-Stroke Depression: A Review
Frank, D., Gruenbaum, B. F., Zlotnik, A. A., Semyonov, M., Frenkel, A., & Boyko, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315114 · Cited by 158
Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder
Khoraminya, N., Tehrani‐Doost, M., Jazayeri, S., Hosseini, A. F., & Djazayery, A. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412465022 · Cited by 147
The Effectiveness of Aromatherapy for Depressive Symptoms: A Systematic Review
Sánchez-Vidaña, D. I., Ngai, S. P. C., He, W., Chow, J. K.-W., Lau, B. W.-M., & Tsang, H. W. H. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/5869315 · Cited by 144
The Depression Treatment Cascade in Primary Care: A Public Health Perspective
Pence, B. W., O’Donnell, J. K., & Gaynes, B. N. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0274-y · Cited by 133
Depression among female psychiatric nurses in southern Taiwan: main and moderating effects of job stress, coping behaviour and social support
Lin, H., Probst, J. C., & Hsu, Y. (2010) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2010.03216.x · Cited by 132
Routledge Handbook of Physical Activity and Mental Health
Panteleimon Ekkekakis, A. (2013) · Routledge eBooks · doi:10.4324/9780203132678 · Cited by 128
Kava and St. John's Wort: Current Evidence for Use in Mood and Anxiety Disorders
Sarris, J. J., & Kavanagh, D. J. (2009) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2009.0066 · Cited by 123
Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: A systematic review and meta-analysis
Usala, T., Clavenna, A., Zuddas, A., & Bonati, M. R. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.06.001 · Cited by 119
Advances in the treatment of depression
Holtzheimer, P. E., & Nemeroff, C. B. (2006) · NeuroRx · doi:10.1016/j.nurx.2005.12.007 · Cited by 119
Psychosocial and pharmacological interventions for depressed adults in primary care: A critical review
Wolf, N. J., & Hopko, D. R. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.04.004 · Cited by 116
Electroacupuncture regulate hypothalamic–pituitary–adrenal axis and enhance hippocampal serotonin system in a rat model of depression
Le, J., Yi, T., Li, Q., Li, J., Shao, L., & Dong, J. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.01.004 · Cited by 113
Antidepressants as analgesics
McCleane, G. (2008) · CNS Drugs · doi:10.2165/00023210-200822020-00005 · Cited by 109
Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder
Wang, Z., Wang, X., Liu, J., Chen, J., Liu, X., Nie, G., Jorgenson, K., Sohn, K. C., Huang, R., Liu, M., et al. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.014 · Cited by 108
Lavender essential oil ameliorates depression-like behavior and increases neurogenesis and dendritic complexity in rats
Sánchez-Vidaña, D. I., Po, K. K. T., Fung, T. K. H., Chow, J. K.-W., Lau, W. K.-W., So, P., Lau, B. W.-M., & Tsang, H. W. H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.042 · Cited by 101
Update in Serotonin and Bone
Bliziotes, M. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0861 · Cited by 102
The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5)
Warden, S. J., Robling, A. G., Haney, E. M., Turner, C. H., & Bliziotes, M. M. (2009) · Bone · doi:10.1016/j.bone.2009.06.029 · Cited by 97
Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
Zhdanov, A. V., Atluri, S., Wong, W., Vaghei, Y., Daskalakis, Z. J., Blumberger, D. M., Frey, B. N., Giacobbe, P., Lam, R. W. M., Milev, R. V., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.18377 · Cited by 95
A 6-week randomized controlled trial with 4-week follow-up of acupuncture combined with paroxetine in patients with major depressive disorder
Qu, S., Huang, Y., Zhang, Z., Chen, J., Lin, R.-Y., Wang, C.-Q., Li, G., Wong, H. K., Zhao, C., Pan, J., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.004 · Cited by 91
Amygdala real‐time functional magnetic resonance imaging neurofeedback for major depressive disorder: A review
Young, K. D., Zotev, V., Phillips, R., Misaki, M., Drevets, W. C., & Bodurka, J. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12665 · Cited by 83
Mouse strain affects behavioral and neuroendocrine stress responses following administration of probiotic Lactobacillus rhamnosus JB-1 or traditional antidepressant fluoxetine
McVey Neufeld, K.-A., Kay, S., & Bienenstock, J. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00294 · Cited by 79
Repeated acupuncture treatments modulate amygdala resting state functional connectivity of depressive patients
Wang, X., Wang, Z., Liu, J., Chen, J., Liu, X., Nie, G., Byun, J.-S., Liang, Y., Park, J., Huang, R., et al. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.07.011 · Cited by 79
Improving the Cost-Effectiveness of a Healthcare System for Depressive Disorders by Implementing Telemedicine: A Health Economic Modeling Study
Lokkerbol, J., Adema, D., Cuijpers, P. J., Reynolds, C. F., Schulz, R., Weehuizen, R., & Smit, F. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.01.058 · Cited by 78
Sexual Dysfunction Due to Psychotropic Medications
Clayton, A. H., Alkis, A. R., Parikh, N., & Votta, J. G. (2016) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2016.04.006 · Cited by 76
Emerging targets for antidepressant therapies
Rakofsky, J. J., Holtzheimer, P. E., & Nemeroff, C. B. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.617 · Cited by 73
Metareview on Short-Term Effectiveness and Safety of Antidepressants for Depression: An Evidence-Based Approach to Inform Clinical Practice
Cipriani, A., Geddes, J. R., Furukawa, T. A., & Barbui, C. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200903 · Cited by 72
Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study
Braak, B., Klooker, T. K., Wouters, M. M., Lei, A., van den Wijngaard, R. M., & Boeckxstaens, G. E. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04775.x · Cited by 72
Paroxetine versus other anti-depressive agents for depression
Purgato, M., Papola, D., Gastaldon, C., Trespidi, C., Magni, L. R., Rizzo, C., Furukawa, T. A., Watanabe, N., Cipriani, A., & Barbui, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006531.pub2 · Cited by 73
A Randomized Trial to Reduce the Prevalence of Depression and Self-Harm Behavior in Older Primary Care Patients
Almeida, O. P., Pirkis, J., Kerse, N. M., Sim, M., Flicker, L. A., Snowdon, J. A., Draper, B., Byrne, G. J., Goldney, R. D., Lautenschlager, N. T., et al. (2012) · The Annals of Family Medicine · doi:10.1370/afm.1368 · Cited by 70
Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice
Kordjazy, N., Haj‐Mirzaian, A., Amiri, S., Ostadhadi, S., Kordjazy, M., Sharifzadeh, M. S., & Dehpour, A. R. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.030 · Cited by 70
A single high dose of escitalopram increases mismatch negativity without affecting processing negativity or P300 amplitude in healthy volunteers
Wienberg, M., Glenthoj, B., Jensen, K., & Oranje, B. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109102606 · Cited by 68
Culturally adapted psychotherapies for depressed adults: A systematic review and meta-analysis
Anik, E., West, R. M., Cardno, A. G., & Mir, G. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.051 · Cited by 65
NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice
Salehi-Sadaghiani, M., Paydar, M. J., Gharedaghi, M. H., Zandieh, A., Heydarpour, P., Yousefzadeh-fard, Y., & Dehpour, A. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2722-0 · Cited by 65
Patterns of benzodiazepine and antidepressant use among middle-aged adults. The Brazilian longitudinal study of adult health (ELSA-Brasil)
Brunoni, A. R., Nunes, M. A., de Figueiredo, R. C., Barreto, S. M., da Fonseca, M. D. J. M., Lotufo, P. A., & Benseñor, I. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.054 · Cited by 64
Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies
Biffi, A., Scotti, L., & Corrao, G. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2187-x · Cited by 60
Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research
Ma, H., Cai, M., & Wang, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.792960 · Cited by 59
“Despite the medications’ well-established treatment efficacy (14, 15), their side effects have also been documented in accumulating studies.”
Background
Dense Cranial Electroacupuncture Stimulation for Major Depressive Disorder—A Single-Blind, Randomized, Controlled Study
Zhang, Z., Ng, R., Man, S. C., Li, T. Y. J., Wong, W., Tan, Q., Wong, H. K., Chung, K., Wong, M.-T., Tsang, W.-K. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029651 · Cited by 59
Limitations of current medical treatments for depression: Disturbed circadian rhythms as a possible therapeutic target
LADER, M. H. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.004 · Cited by 61
Americans' Attitudes Toward Psychiatric Medications: 1998–2006
Mojtabai, R. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.8.1015 · Cited by 57
Relationship of Mean Platelet Volume To MDD: A Retrospective Study.
(2017) · doi:10.11919/j.issn.1002-0829.216082 · Cited by 54
Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests
Haj‐Mirzaian, A., Kordjazy, N., Haj‐Mirzaian, A., Ostadhadi, S., Ghasemi, M., Amiri, S., Faizi, M., & Dehpour, A. R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4004-0 · Cited by 56
Milnacipran versus other antidepressive agents for depression
Nakagawa, A., Watanabe, N., Omori, I. M., Barbui, C., Cipriani, A., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006529.pub2 · Cited by 54
Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels
Warden, S. J., Hassett, S. M., Bond, J. L., Rydberg, J., Grogg, J. D., Hilles, E. L., Bogenschutz, E. D., Smith, H. D., Fuchs, R. K., Bliziotes, M. M., et al. (2010) · Bone · doi:10.1016/j.bone.2009.12.031 · Cited by 56
Molecular genetics in psychology and personality neuroscience: On candidate genes, genome wide scans, and new research strategies
Montag, C., Ebstein, R. P., Jawinski, P., & Markett, S. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.06.020 · Cited by 58
A dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey
Oikonomidis, L., Santangelo, A. M., Shiba, Y., Clarke, F. H., Robbins, T. W., & Roberts, A. C. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22446 · Cited by 54
Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities
Baghai, T. C., Volz, H., & Möller, H. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970601003973 · Cited by 53
Acupuncture Activates ERK-CREB Pathway in Rats Exposed to Chronic Unpredictable Mild Stress
Lü, J., Liang, J., Wang, J.-R., Hu, L., Tu, Y., & Guo, J. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/469765 · Cited by 53
Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies.
Warden, S. J., & Haney, E. M. (2008) · PubMed · Cited by 53
Depression in adults: drug and physical treatments.
Barbui, C., Butler, R., Cipriani, A., Geddes, J. R., & Hatcher, S. (2007) · Europe PMC (PubMed Central) · Cited by 52
Depression profile in patients with and without chronic heart failure
Holzapfel, N., Müller‐Tasch, T., Wild, B., Jünger, J., Zugck, C., Remppis, A. B., Herzog, W., & Löwe, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.04.009 · Cited by 52
Medication beliefs and adherence to antidepressants in primary care
Russell, J., & Kazantzis, N. (2008) · PubMed · doi:10.26181/22201684 · Cited by 52
Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis
Undurraga, J. P., & Baldessarini, R. J. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711709 · Cited by 51
Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care
Eveleigh, R. M., Muskens, E., Lucassen, P. L., Verhaak, P. F. M., Spijker, J., van Weel, C., Voshaar, R. C. O., & Speckens, A. E. M. (2017) · BJGP Open · doi:10.3399/bjgpopen17x101265 · Cited by 52
Neuro-nutraceutical potential of Asparagus racemosus: A review
Majumdar, S., Gupta, S., Prajapati, S. K., & Krishnamurthy, S. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105013 · Cited by 54
Patientenbeteiligung bei medizinischen Entscheidungen
Loh, A., Simón, D., Niebling, W., & Härter, M. C. (2005) · Zeitschrift für Allgemeinmedizin · doi:10.1007/bf03652169 · Cited by 49
Transglutaminase 2-mediated serotonylation in pulmonary hypertension
Penumatsa, K. C., & Fanburg, B. L. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00321.2013 · Cited by 49
Cross-sectional survey of patients in receipt of long-term repeat prescriptions for antidepressant drugs in primary care.
Cruickshank, G., MacGillivray, S. A., Bruce, D. G., Mather, A., Matthews, K., & Williams, B. (2008) · Discovery Research Portal (University of Dundee) · Cited by 48
The Mind Body Connection in Dermatologic Conditions: A Literature Review
Mar, K., & Rivers, J. K. (2023) · Journal of Cutaneous Medicine and Surgery · doi:10.1177/12034754231204295 · Cited by 54
Antidepressant Treatment for Postnatal Depression
Molyneaux, E., Trevillion, K., & Howard, L. M. (2015) · JAMA · doi:10.1001/jama.2015.2276 · Cited by 46
Antidepressant Self-Discontinuation: Results From the Collaborative Psychiatric Epidemiology Surveys
Samples, H., & Mojtabai, R. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400021 · Cited by 45
Cost-effectiveness of collaborative care including PST and an antidepressant treatment algorithm for the treatment of major depressive disorder in primary care; a randomised clinical trial
IJff, M. A., Huijbregts, K. M. L., van Marwijk, H., Beekman, A. T. F., Roijen, L. H., Rutten, F., Unützer, J., & Feltz-Cornelis, C. M. V. D. (2007) · BMC Health Services Research · doi:10.1186/1472-6963-7-34 · Cited by 48
Systematic review of interventions for depression and anxiety in persons with inflammatory bowel disease
for the CIHR Team “Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease”, Fiest, K. M., Bernstein, C. N., Walker, J. R., Graff, L. A., Hitchon, C. A., PESCHKEN, C. A., Zarychanski, R., Abou-Setta, A. M., Patten, S. B., et al. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2204-2 · Cited by 46
Altered amygdala resting-state functional connectivity following acupuncture stimulation at BaiHui (GV20) in first-episode drug-Naïve major depressive disorder
Duan, G., He, Q., Pang, Y., Chen, W., Liao, H., Liu, H., Tan, L., Liu, Y., Tao, J., Zhang, J., et al. (2019) · Brain Imaging and Behavior · doi:10.1007/s11682-019-00178-5 · Cited by 43
Effectiveness of antidepressants
McCormack, J. P., & Korownyk, C. S. (2018) · BMJ · doi:10.1136/bmj.k1073 · Cited by 42
Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test
Haj-Mirzaian, A., Kordjazy, N., Amiri, S., Haj-Mirzaian, A., Amini-khoei, H., Ostadhadi, S., & Dehpour, A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.034 · Cited by 42
Efficacy and tolerability of antidepressants for sub-threshold depression and for mild major depressive disorder
Cameron, I. M., Reid, I., & MacGillivray, S. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.078 · Cited by 44
Pharmacological management of unipolar depression
Malhi, G. S., Hitching, R., Berk, M., Boyce, P. M., Porter, R., & Fritz, K. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12122 · Cited by 41
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder
Tini, E., Smigielski, L., Romanos, M., Wewetzer, C., Karwautz, A. F. K., Reitzle, K., Correll, C. U., Plener, P. L., Malzahn, U., Heuschmann, P. U., et al. (2022) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2022.152301 · Cited by 43
Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl- d -aspartate and opioid receptors
Haj‐Mirzaian, A., Kordjazy, N., Ostadhadi, S., Amiri, S., Haj‐Mirzaian, A., & Dehpour, A. R. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2015-0429 · Cited by 41
Entwicklungsprozess der DGPPN-Qualitätsindikatoren
Großimlinghaus, I., Falkai, P., Gäebel, W., Janssen, B., Reich‐Erkelenz, D., Wobrock, T., & Zielasek, J. (2013) · Der Nervenarzt · doi:10.1007/s00115-012-3705-4 · Cited by 40
Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability
Fregni, F., Brunoni, & Fráguas, R. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5751 · Cited by 40
Enhanced Antidepressant-Like Effects of Electroacupuncture Combined with Citalopram in a Rat Model of Depression
Yang, J., Pei, Y., Pan, Y., Jia, J., Shi, C., Yu, Y., Deng, J., Li, B., Gong, X., Wang, X., et al. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/107380 · Cited by 40

Authors: Arroll, B.
Affiliations: University of Auckland (NZ)
Corresponding author: Arroll, B.
ORCID: Arroll, B.
Venue: The Annals of Family Medicine
Publisher: Annals of Family Medicine
Published: 2005-09-01
Volume: 3
Issue: 5
Pages: 449-456
ISSN: 1544-1709 (ISSN-L)
1544-1717
DOI: 10.1370/afm.349
PMC: PMC1466912
OpenAlex: W2121920106
Cited by: 351
References: 40
Citations by year: 2026: 8 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 16 · 2021: 21 · 2020: 14 · 2019: 13 · 2018: 15 · 2017: 19 · 2016: 31 · 2015: 21 · 2014: 16 · 2013: 20 · 2012: 18
FWCI: 2.33
Type: journal article
Language: en
Open access: diamond
doi.org
Locations: The Annals of Family Medicine (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
Edinburgh Napier Research Repository (Edinburgh Napier University) (submittedVersion, cc-by)
Edinburgh Napier Research Repository (Edinburgh Napier University) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: depression, tricyclic antidepressants, selective serotonin reuptake inhibitors, antidepressant efficacy, antidepressant tolerability, placebo comparison, primary care, adverse effects, number needed to treat, number needed to harm, treatment response, antidepressant discontinuation, depression scores
MeSH terms: Antidepressive Agents, Tricyclic, Depressive Disorder, Humans, Placebos, Primary Health Care, Placebo Effect, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Efficacy and Tolerability of Tricyclic Antidepressants and SSRIs Compared With Placebo for Treatment of Depression in Primary Care: A Meta-Analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks